TELA Bio (TELA) Deferred Taxes (2025)
TELA Bio's quarterly Deferred Taxes came in at $59000.0 in Q4 2025, up 78.79% quarter-over-quarter from $33000.0 in Q2 2025.
TELA Bio has reported Deferred Taxes for 1 years, with the latest figure at $59000.0 in Q4 2025.
- For the quarter ending Q4 2025, Deferred Taxes changed N/A year-over-year to $59000.0; the trailing twelve-month figure through Dec 2025 stood at $144000.0 (changed N/A YoY), and the FY2025 full-year result was $144000.0, up 200.0% from the prior year.
- Deferred Taxes for Q4 2025 stood at $59000.0, up from $33000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $59000.0 in Q4 2025, with the low at $33000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -101.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 300,000.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -16.70 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 52,000.00 |